Spyre Therapeutics (SYRE) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.99% |
| Dec 31, 2025 | -55.60% |
| Sep 30, 2025 | 7.67% |
| Jun 30, 2025 | 6.49% |
| Mar 31, 2025 | 6.36% |
| Dec 31, 2024 | -45.78% |
| Sep 30, 2024 | 3.16% |
| Jun 30, 2024 | 12.10% |
| Mar 31, 2024 | -42.85% |
| Dec 31, 2023 | -66.64% |
| Sep 30, 2023 | 13.49% |
| Jun 30, 2023 | -511.67% |
| Mar 31, 2023 | 30.93% |
| Dec 31, 2022 | 24.38% |
| Sep 30, 2022 | 16.80% |
| Jun 30, 2022 | -32.71% |
| Mar 31, 2022 | 28.35% |
| Dec 31, 2021 | 17.17% |
| Sep 30, 2021 | 12.56% |
| Jun 30, 2021 | -1.51% |
| Mar 31, 2021 | 13.41% |
| Dec 31, 2020 | -4.50% |
| Sep 30, 2020 | 11.26% |
| Jun 30, 2020 | -221.95% |
| Mar 31, 2020 | 31.91% |
| Dec 31, 2019 | 18.89% |
| Sep 30, 2019 | 15.96% |
| Jun 30, 2019 | -62.59% |
| Mar 31, 2019 | 12.88% |
| Dec 31, 2018 | -18.27% |
| Sep 30, 2018 | 12.73% |
| Jun 30, 2018 | -78.98% |
| Mar 31, 2018 | 19.81% |
| Dec 31, 2017 | 6.50% |
| Sep 30, 2017 | 15.14% |
| Jun 30, 2017 | -9.55% |
| Mar 31, 2017 | 8.87% |
| Dec 31, 2016 | 6.66% |
| Sep 30, 2016 | 7.53% |
| Jun 30, 2016 | -153.83% |
| Mar 31, 2016 | 12.33% |
| Dec 31, 2015 | -7.20% |
| Sep 30, 2015 | 21.09% |
| Jun 30, 2015 | 10.76% |